Mediators and moderators of cognitive behavioral therapy for childhood anxiety disorders: information processing, emotion regulation and stress reactivity

ISRCTN ISRCTN46352117
DOI https://doi.org/10.1186/ISRCTN46352117
Secondary identifying numbers N/A
Submission date
26/09/2006
Registration date
26/09/2006
Last edited
06/01/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr F Boer
Scientific

Academic Medical Center (AMC)
Department of Child and Adolescent Psychiatry/de Bascule
PO Box 12474
Amsterdam
1100 AL
Netherlands

Phone +31 (0)20 5663383
Email f.boer@amc.uva.nl

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific titleMediators and moderators of cognitive behavioral therapy for childhood anxiety disorders: information processing, emotion regulation and stress reactivity
Study objectives1. Changes in outcome measures of anxiety can be partly explained by changes in:
a. self-reported thoughts
b. selective attention and by changes in fear relevant cognitive schema's
2. Changes in outcome measures of anxiety can be partly explained by changes in:
a. self-reported emotion regulation strategies
b. processes of attention regulation and by changes in underlying schema's of 'perceived control'
3. Effortful control will moderate the treatment effect
4. Executive functions will moderate the relation between mediators and the treatment effect. The treatment effect will be larger when executive functions are more developed
5. Stress-reactivity will moderate the treatment effect
6. Stress-reactivity is a vulnerability factor for developing an anxiety disorder and is an effect of an anxiety disorder
7. Part of the variance in treatment effect can be explained by family characteristics (parents psychopathology and parenting style) and characteristics of the therapist
Ethics approval(s)Ethics approval received from the local medical ethics committee
Health condition(s) or problem(s) studiedAnxiety disorders
InterventionGroup one: 12 sessions of Cognitive Behavioural Therapy (CBT) according to the Coping Cat manual.
Four measure points: before therapy, after eight sessions, after therapy and after 12 week follow-up period.

Group two: Eight week Waiting List (WL) group. Children will receive the same therapy as group one after the waiting period.
Five measure points: before waiting list, before therapy, after eight sessions of therapy, after therapy and after 12 week follow-up period
Intervention typeOther
Primary outcome measure1. Effect of treatment (diagnosis of anxiety disorder and scores on anxiety questionnaires)
2. Mediating effect of information processing
3. Mediating effect of emotion regulation
4. Moderating effect of effortful control, executive functions and stress-reactivity
Secondary outcome measures1. Correlation between explicit and implicit measures
2. Development of implicit measures
Overall study start date01/09/2006
Completion date01/09/2008

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit7 Years
Upper age limit18 Years
SexBoth
Target number of participants120
Total final enrolment145
Key inclusion criteria1. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) anxiety disorder as primary diagnosis
2. Age between seven and 18 years
3. Intelligence Quotient (IQ) more than or equal to 80
4. Informed consent from parents and child
Key exclusion criteria1. Psychosis
2. Obsessive compulsive disorder as primary disorder
3. Post-traumatic stress disorder as primary disorder
4. Acute stress disorder
5. Drug and/or alcohol problems
6. Selective mutism
7. Current treatment with Selective Serotonin Reuptake Inhibitor (SSRI) or treatment with SSRI within half a year before inclusion
8. Psychotherapeutic treatment within the last half year
Date of first enrolment01/09/2006
Date of final enrolment01/09/2008

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Academic Medical Center (AMC)
Amsterdam
1100 AL
Netherlands

Sponsor information

Academic Medical Center
University/education

PO Box 22660
Amsterdam
1100 DD
Netherlands

Website https://www.amc.nl/web/Zorg.htm
ROR logo "ROR" https://ror.org/03t4gr691

Funders

Funder type

University/education

Universiteit van Amsterdam
Government organisation / Universities (academic only)
Alternative name(s)
University of Amsterdam, UvA
Location
Netherlands
Accare (The Netherlands)
Private sector organisation / Other non-profit organizations
Location
Netherlands
Academic Medical Center (AMC) (The Netherlands)
Private sector organisation / Universities (academic only)
Alternative name(s)
Academic Medical Center, AMC
Location
Netherlands

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/04/2013 06/01/2021 Yes No

Editorial Notes

06/01/2021: Publication reference and total final enrolment added.